I think management is not as bad as many people think, of course they have they flaws and they need some punishment like shareholders voting no to their cheap options. Delays in patient finding its not their fault, the criteria selection is very strict (if someone doubt it, read it and you will see), and each site is responsible to recruit patients. Remember, this technology is the first time that it is being tested in humans, we are breaking in new ground here, and possible new disrupting technology.
We are going in good direction, until we prove TT-034 works there are little tools to negotiate with big pharma, and if we do It, It will be in weaker terms than after efficacy proven. Once efficacy proven if they are not able to find big pharma deal, then yes, shame on them.
BLT Price at posting:
42.0¢ Sentiment: Buy Disclosure: Held
